Will the frenzy of gene patenting drive innovation-or stifle medical advances?
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
Biomedicine: Scarcity of stem cells blocks biomedical progress
Biotechnology: Firm set to mine Framingham Heart Study.
DNA-based PCs? Doubtful. But DNA might do some computing-while assembling nanostructures.
DNA is Wall Street's latest craze.
The latest commercial Web offering: genetic data.